{"schema_version":"alpha-company-profile-public-v2","slug":"regeneron-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc","published_on":"2026-09-21T04:45:16.68769+00:00","last_reviewed_on":"2026-09-21T04:45:16.68769+00:00","identity":{"legal_name":"REGENERON PHARMACEUTICALS, INC.","display_name":"Regeneron Pharmaceuticals","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for Regeneron Pharmaceuticals.","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"NY","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"https://www.regeneron.com","cik":"0000872589","logo":"https://cdn.brandfetch.io/regeneron.com","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/regeneron.com","alt":"Regeneron Pharmaceuticals logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-21T04:45:16.68769+00:00"},"security_listings":[{"ticker":"REGN","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"REGENERON PHARMACEUTICALS, INC.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Jurisdiction","value":"NY","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Official website","value":"https://www.regeneron.com","source_id":"alpha-company-website-provenance"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[{"label":"Visit official website","href":"https://www.regeneron.com","emphasis":"primary"}],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/regeneron-pharmaceuticals-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-21T04:45:16.68769+00:00"},{"id":"alpha-company-website-provenance","label":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","href":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_type":"SEC filing","supports":["Official website"],"status":"published","reviewed_on":"2026-08-29T22:22:03Z"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[{"predicate":"organization.financial_scale.net_income","object":{"fy":2025,"form":"10-K","unit":"USD","value":4504900000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.financial_scale.revenue","object":{"fy":2025,"form":"10-K","unit":"USD","value":14342900000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.financial_scale.total_assets","object":{"fy":2025,"form":"10-K","unit":"USD","value":40558700000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.shares_outstanding","object":{"unit":"shares","as_of":"2012-02-10","class":"common stock","shares":91779465},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"}],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[{"predicate":"organization.beneficial_owner","object":{"name":"Huda Y. Zoghbi, M.D.","shares":30679,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Daniel P. Van Plew","shares":105548,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Craig B. Thompson, M.D.","shares":8811,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"George L. Sing","shares":69163,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"David P. Schenkein, M.D.","shares":6586,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Arthur F. Ryan","shares":26582,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Christine A. Poon","shares":41225,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Andrew J. Murphy, Ph.D.","shares":246030,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Joseph J. LaRosa","shares":182611,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Kathryn Guarini, Ph.D.","shares":6586,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Joseph L. Goldstein, M.D.","shares":12975,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Christopher Fenimore","shares":93920,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"N. Anthony Coles, M.D.","shares":10693,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Michael S. Brown, M.D.","shares":19137,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Bonnie L. Bassler, Ph.D.","shares":17912,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"George D. Yancopoulos, M.D., Ph.D.","shares":42750,"percent":2.4,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"BlackRock, Inc.","shares":8629707,"percent":8.4,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Capital World Investors 5","shares":5194729,"percent":5,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"BlackRock, Inc. 4 55 East 52nd Street","shares":8629707,"percent":8.4,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"The Vanguard Group, Inc. 3","shares":8838240,"percent":8.6,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"}],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":26,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":5,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":26,"corroborated_claims":0,"sources":5,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-09-21T04:45:16.68769+00:00","observed_at":"2026-09-21T04:45:16.68769+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"regeneron-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc"},"publication":{"published_at":"2026-09-21T04:45:16.68769+00:00","last_reviewed_at":"2026-09-21T04:45:16.68769+00:00","as_of":"2026-09-21T04:45:16.68769+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"regeneron-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc","as_of":"2026-09-21T04:45:16.68769+00:00","last_reviewed_at":"2026-09-21T04:45:16.68769+00:00","identity":{"legal_name":"REGENERON PHARMACEUTICALS, INC.","display_name":"Regeneron Pharmaceuticals","description":null,"jurisdiction":"NY","country":"US","sector":"Healthcare","industry":null,"website":"https://www.regeneron.com","website_provenance":{"website":"https://www.regeneron.com","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","retrieved_at":"2026-08-29T22:22:03Z","schema_version":"alpha-website-provenance-v1","source":"sec_10k_item_1","source_name":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","excerpt":"s Corporate Information We make available free of charge on or through our Internet website ( http://www.regeneron.com )","rights":"public_record_sec_filing"},"logo_url":"https://cdn.brandfetch.io/regeneron.com","logo_media":null,"status":"active","cik":"0000872589","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"REGN","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"5c4bd04c-a80d-4e3d-8a4e-dcaf1f74b501","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-21","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"arthur-f-ryan","display_name":"Anita J. Ryan","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2003-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/32bdbb6f-47ee-4d0a-9595-4788d79bcd5a.jpg"},{"person_slug":"bonnie-l-bassler","display_name":"Bonnie L. Bassler","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/0903f9be-9841-451d-82f4-19a823eee4b0.jpg"},{"person_slug":"christine-a-poon","display_name":"Christine A. Poon","role_category":"director","title":"Lead Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/67415eb1-26e4-497e-bc72-d3adfdede06d.jpg"},{"person_slug":"craig-b-thompson","display_name":"Craig B. Thompson","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ae740981-b7bf-4e7f-92fb-0dc504ef96c4.jpg"},{"person_slug":"david-p-schenkein","display_name":"David P. Schenkein","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/1fe69dcc-b674-4456-b29d-c36bddfa3d43.jpg"},{"person_slug":"george-d-yancopoulos","display_name":"George D. Yancopoulos","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2001-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/9ee840ac-16a5-46a7-bea2-656811578657.jpg"},{"person_slug":"george-l-sing","display_name":"George L. Sing","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1988-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/1f2f3528-371e-496e-a029-7489dd7952ff.jpg"},{"person_slug":"huda-y-zoghbi","display_name":"Huda Y. Zoghbi","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/456e84a3-eef6-47ab-90cb-b87d304f68a4.jpg"},{"person_slug":"joseph-l-goldstein","display_name":"Joseph L. Goldstein","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":null},{"person_slug":"kathryn-guarini","display_name":"Kathryn Guarini","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/447ede12-c918-4aa4-811e-710878eb3052.jpg"},{"person_slug":"leonard-s-schleifer","display_name":"Leonard S. Schleifer","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"1988-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/4d88742f-34d6-4df5-96e7-d5c05447e0e6.jpg"},{"person_slug":"michael-s-brown","display_name":"Michael S. Brown","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/ed5428d7-c6ce-46f9-a881-33bf11c493ac.jpg"},{"person_slug":"n-anthony-coles","display_name":"N. Anthony Coles","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T20:10:05.384+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/c2a41d64-572c-4946-b4f0-d47195897781.jpg"}],"executives":[{"person_slug":"andrew-j-murphy-ph-d","display_name":"Andrew J. Murphy, Ph.D.","role_category":"executive","title":"Executive Vice President, Co-Chief Scientific Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000340","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_def_14a","published_at":"2026-04-24T00:00:00+00:00","effective_date":"2026-04-24","last_checked_at":"2026-09-14T16:52:57.731588+00:00"},"headshot_url":null},{"person_slug":"christopher-fenimore","display_name":"Christopher Fenimore","role_category":"executive","title":"Executive Vice President, Finance and Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000340","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_def_14a","published_at":"2026-04-24T00:00:00+00:00","effective_date":"2026-04-24","last_checked_at":"2026-09-14T16:52:57.731588+00:00"},"headshot_url":null},{"person_slug":"daniel-p-van-plew","display_name":"Daniel P. Van Plew","role_category":"executive","title":"Executive Vice President and General Manager, Industrial Operations and Product Supply","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000340","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_def_14a","published_at":"2026-04-24T00:00:00+00:00","effective_date":"2026-04-24","last_checked_at":"2026-09-14T16:52:57.731588+00:00"},"headshot_url":null},{"person_slug":"george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","display_name":"George D. Yancopoulos, M.D., Ph.D.","role_category":"executive","title":"Board co-Chair, President and Chief Scientific Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000340","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_def_14a","published_at":"2026-04-24T00:00:00+00:00","effective_date":"2026-04-24","last_checked_at":"2026-09-14T16:52:57.731588+00:00"},"headshot_url":null},{"person_slug":"leonard-s-schleifer","display_name":"Leonard S. Schleifer","role_category":"executive","title":"Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-04","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"REGN 10-K executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_type":"sec_filing","published_at":"2026-02-04T00:00:00+00:00","effective_date":"2026-02-04","last_checked_at":"2026-07-11T00:40:32.155611+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/4d88742f-34d6-4df5-96e7-d5c05447e0e6.jpg"},{"person_slug":"leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","display_name":"Leonard S. Schleifer, M.D., Ph.D.","role_category":"executive","title":"Board co-Chair, President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000340","source_url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_type":"sec_def_14a","published_at":"2026-04-24T00:00:00+00:00","effective_date":"2026-04-24","last_checked_at":"2026-09-14T16:52:57.731588+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc#profile","url":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc","dateModified":"2026-09-21T04:45:16.68769+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc#organization","legalName":"REGENERON PHARMACEUTICALS, INC.","name":"Regeneron Pharmaceuticals","url":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc","sameAs":["https://www.regeneron.com"],"logo":"https://cdn.brandfetch.io/regeneron.com","addressCountry":"US","indexMembership":[{"@type":"alpha:IndexMembership","@id":"https://api.alpha.ac/v1/index-memberships/63fd8cba-cc87-48fb-bc3f-f323bf9aec40","name":"S&P 500","indexProvider":"S&P Dow Jones Indices","indexMembershipStatus":"current","indexEffectiveDate":"2013-05-01","lastVerifiedAt":"2026-09-02T01:46:54.035948+00:00","verificationStatus":"inferred","evidence":"https://www.slickcharts.com/sp500","additionalProperty":[{"@type":"PropertyValue","name":"index_id","value":"alpha:index:sp-500"},{"@type":"PropertyValue","name":"security_id","value":"alpha:security:31a399fe24237fb804644cba938c74d3"},{"@type":"PropertyValue","name":"listing_id","value":"5c4bd04c-a80d-4e3d-8a4e-dcaf1f74b501"},{"@type":"PropertyValue","name":"ticker","value":"REGN"},{"@type":"PropertyValue","name":"exchange","value":"NASDAQ"},{"@type":"PropertyValue","name":"MIC","value":"XNAS"}]},{"@type":"alpha:IndexMembership","@id":"https://api.alpha.ac/v1/index-memberships/6e557044-f979-4378-ad18-f3fab7f2af20","name":"Nasdaq-100","indexProvider":"Nasdaq","indexMembershipStatus":"current","indexEffectiveDate":"2026-09-01","lastVerifiedAt":"2026-09-02T01:47:46.199772+00:00","verificationStatus":"exchange_verified","evidence":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","additionalProperty":[{"@type":"PropertyValue","name":"index_id","value":"alpha:index:nasdaq-100"},{"@type":"PropertyValue","name":"security_id","value":"alpha:security:31a399fe24237fb804644cba938c74d3"},{"@type":"PropertyValue","name":"listing_id","value":"5c4bd04c-a80d-4e3d-8a4e-dcaf1f74b501"},{"@type":"PropertyValue","name":"ticker","value":"REGN"},{"@type":"PropertyValue","name":"exchange","value":"NASDAQ"},{"@type":"PropertyValue","name":"MIC","value":"XNAS"}]}],"member":[{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2003-01-01","member":{"@type":"Person","name":"Anita J. Ryan","url":"https://registry.alpha.ac/people/arthur-f-ryan"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2016-01-01","member":{"@type":"Person","name":"Bonnie L. Bassler","url":"https://registry.alpha.ac/people/bonnie-l-bassler"}},{"@type":"OrganizationRole","roleName":"Lead Independent Director","startDate":"2010-01-01","member":{"@type":"Person","name":"Christine A. Poon","url":"https://registry.alpha.ac/people/christine-a-poon"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Craig B. Thompson","url":"https://registry.alpha.ac/people/craig-b-thompson"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2023-01-01","member":{"@type":"Person","name":"David P. Schenkein","url":"https://registry.alpha.ac/people/david-p-schenkein"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2001-01-01","member":{"@type":"Person","name":"George D. Yancopoulos","url":"https://registry.alpha.ac/people/george-d-yancopoulos"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"1988-01-01","member":{"@type":"Person","name":"George L. Sing","url":"https://registry.alpha.ac/people/george-l-sing"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2016-01-01","member":{"@type":"Person","name":"Huda Y. Zoghbi","url":"https://registry.alpha.ac/people/huda-y-zoghbi"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"1991-01-01","member":{"@type":"Person","name":"Joseph L. Goldstein","url":"https://registry.alpha.ac/people/joseph-l-goldstein"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Kathryn Guarini","url":"https://registry.alpha.ac/people/kathryn-guarini"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"1988-01-01","member":{"@type":"Person","name":"Leonard S. Schleifer","url":"https://registry.alpha.ac/people/leonard-s-schleifer"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"1991-01-01","member":{"@type":"Person","name":"Michael S. Brown","url":"https://registry.alpha.ac/people/michael-s-brown"}},{"@type":"OrganizationRole","roleName":"Independent Director","startDate":"2017-01-01","member":{"@type":"Person","name":"N. Anthony Coles","url":"https://registry.alpha.ac/people/n-anthony-coles"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Co-Chief Scientific Officer","member":{"@type":"Person","name":"Andrew J. Murphy, Ph.D.","url":"https://registry.alpha.ac/people/andrew-j-murphy-ph-d"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Finance and Chief Financial Officer","member":{"@type":"Person","name":"Christopher Fenimore","url":"https://registry.alpha.ac/people/christopher-fenimore"}},{"@type":"OrganizationRole","roleName":"Executive Vice President and General Manager, Industrial Operations and Product Supply","member":{"@type":"Person","name":"Daniel P. Van Plew","url":"https://registry.alpha.ac/people/daniel-p-van-plew"}},{"@type":"OrganizationRole","roleName":"Board co-Chair, President and Chief Scientific Officer","member":{"@type":"Person","name":"George D. Yancopoulos, M.D., Ph.D.","url":"https://registry.alpha.ac/people/george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc"}},{"@type":"OrganizationRole","roleName":"Chief Executive Officer","startDate":"2026-02-04","member":{"@type":"Person","name":"Leonard S. Schleifer","url":"https://registry.alpha.ac/people/leonard-s-schleifer"}},{"@type":"OrganizationRole","roleName":"Board co-Chair, President and Chief Executive Officer","member":{"@type":"Person","name":"Leonard S. Schleifer, M.D., Ph.D.","url":"https://registry.alpha.ac/people/leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc"},"financials":{"kind":"financials","records":[{"predicate":"organization.financial_scale.net_income","object":{"fy":2025,"form":"10-K","unit":"USD","value":4504900000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.financial_scale.revenue","object":{"fy":2025,"form":"10-K","unit":"USD","value":14342900000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.financial_scale.total_assets","object":{"fy":2025,"form":"10-K","unit":"USD","value":40558700000,"accession":"0000872589-26-000008","period_end":"2025-12-31"},"confidence":0.95,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"173e85b3-40fe-44c7-85ff-d172e0220fcc"},{"predicate":"organization.shares_outstanding","object":{"unit":"shares","as_of":"2012-02-10","class":"common stock","shares":91779465},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"}],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[{"predicate":"organization.beneficial_owner","object":{"name":"Huda Y. Zoghbi, M.D.","shares":30679,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Daniel P. Van Plew","shares":105548,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Craig B. Thompson, M.D.","shares":8811,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"George L. Sing","shares":69163,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"David P. Schenkein, M.D.","shares":6586,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Arthur F. Ryan","shares":26582,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Christine A. Poon","shares":41225,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Andrew J. Murphy, Ph.D.","shares":246030,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Joseph J. LaRosa","shares":182611,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Kathryn Guarini, Ph.D.","shares":6586,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Joseph L. Goldstein, M.D.","shares":12975,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Christopher Fenimore","shares":93920,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"N. Anthony Coles, M.D.","shares":10693,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Michael S. Brown, M.D.","shares":19137,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Bonnie L. Bassler, Ph.D.","shares":17912,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"George D. Yancopoulos, M.D., Ph.D.","shares":42750,"percent":2.4,"holder_type":"insider"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"BlackRock, Inc.","shares":8629707,"percent":8.4,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"Capital World Investors 5","shares":5194729,"percent":5,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"BlackRock, Inc. 4 55 East 52nd Street","shares":8629707,"percent":8.4,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"},{"predicate":"organization.beneficial_owner","object":{"name":"The Vanguard Group, Inc. 3","shares":8838240,"percent":8.6,"holder_type":"gt5"},"confidence":0.9,"observed_at":"2026-08-29T07:00:00+00:00","assertion_state":"asserted","source_record_id":"7fd046c7-0c37-4b10-a1db-e7b9c2945897"}],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}